Philippines government investigates Dengvaxia dengue vaccine

Share

The Philippines banned a government program, which involved immunizing children with Dengvaxia after releasing Sanofi's findings. The WHO Country Office said this position paper was "based on recommendations of the Strategic Group of Experts on Immunisation which met and published preliminary advice in mid-April 2016".

A statement from Sanofi said the long-term trial results highlighted "the complex nature" of dengue infection as it proposed a "label update" on the use of the vaccine.

Philippine health officials have ordered Sanofi to jerk its dengue vaccine off the market as the controversy over the health threat it poses to children continues to roil the country.

On the impact of issues surrounding the vaccine in Brazil and the Philippines, the spokesperson said, "Sanofi Pasteur has taken action to transparently share this new data with the health authorities in the countries where the vaccine is in use today or where it is now being considered for regulatory approval".

"In this group, all fully recovered with proper medical treatment".

To allay the fears of the public, Malacañang on Monday reminded the public to not panic over the government's dengue vaccination program, saying the Department of Justice (DOJ) will start an inquiry on the purchase of the drug.

Читайте также: Sharad Yadav speaks after RS disqualification: My fight for democracy will continue

"These included the following: first, use of the vaccine should only be considered in areas where a high proportion (preferably at least 70%) of the community had already been exposed to the virus; second, the vaccine should only be provided to people 9 years of age and above; and third, people being vaccinated should receive 3 doses", it said.

The WHO said on Monday it hoped to review safety data this month on Sanofi's dengue vaccine which the company said was approved in 19 countries and launched in 11.

The FDA added they are closely coordinating with DOH for any "adverse events and reactions" that may be reported by the recipients following their immunization of Dengvaxia, and vowed to immediately take appropriate measures to protect the public.

As of November 2017, about 733,713 Filipino children have been given the anti-dengue vaccine.

Dengue is a mosquito-borne tropical disease that kills about 20,000 people a year and infects hundreds of millions.

При любом использовании материалов сайта и дочерних проектов, гиперссылка на обязательна.
«» 2007 - 2017 Copyright.
Автоматизированное извлечение информации сайта запрещено.

Код для вставки в блог

Share